No Data
No Data
Kinden, Cosmos Pharmaceuticals, etc. (added) Rating
Downgrading-Bearish Code | Stock Name | Securities Company | Conventional | After Change |------|---------|---------|---------|<8515>|AIFUL | Mizuho | “Buy” | “Neutral” | Target Stock Price Change Code | Stock Name | Securities Company | Traditional | After Change |------|-|----
COSMOS PHARMACEUTICAL CORP (CSMYF.US) will release financial results on April 12
$COSMOS PHARMACEUTICAL CORP (CSMYF.US) $ will release financial results on April 12, investors stay tuned. What are the previous results? $COSMOS PHARMACEUTICAL CORP (CSMYF.US) $2024/Q2 operating income of 234.777 billion yen, net profit of 5,079 billion yen, and earnings per share of 128.18 yen. 2023/Q3 operating income of 202.286 billion yen, net profit of 4.984 billion yen, earnings per share of 125.862
No Data